Endogenous virus and hepatitis C virus-like particle budding in BHK-21 cells.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Preclinical Development and Production of Virus-Like Particles As Vaccine Candidates for Hepatitis C.Frontiers in microbiology · 2017
   Review
2. Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus.Journal of virology · 2011
   Article
3. Refined methods for propagating vesicular stomatitis virus vectors that are defective for G protein expression.Journal of virological methods · 2010
   Article
4. Membrane binding properties and terminal residues of the mature hepatitis C virus capsid protein in insect cells.Journal of virology · 2004
   Article
5. Hepatitis C virus-like particle budding: role of the core protein and importance of its Asp111.Journal of virology · 2003
   Article

Corrections and comments

• Comment on
  Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector.2002

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as